The chart below identifies updates to our Pharmacy program. For additional details, refer to the Pharmacy Medical Necessity Guidelines page on our Point32Health provider website, where you can find the policies that detail coverage criteria for our Harvard Pilgrim and Tufts Health Plan lines of business.
| Updates to existing prior authorization programs
Visit the Pharmacy Medical Necessity Guidelines page on our Point32Health provider website for details. |
||
| Drug/policy | Plan & additional information | Eff. date |
| Synarel
Endocrine Agents
|
Harvard Pilgrim Commercial, Tufts Health Plan Commercial, Tufts Health Direct | 7/1/2024 |
| Vtama
Zoryve Dermatological Immunomodulators
|
Harvard Pilgrim Commercial, Tufts Health Plan Commercial, Tufts Health Direct | 7/1/2024 |
| Drug status changes | ||
| Drug | Plan & additional information | Eff. date |
| GlucaGen HypoKit | Harvard Pilgrim Commercial, Tufts Health Plan Commercial, Tufts Health Direct
Glucagen HypoKit will be discontinued on 7/1/2024 and will move to Nonformulary status. |
7/1/2024 |
Audrey Kleinberg,
Director, Provider Relations & Communications
Annmarie Dadoly,
Senior Manager, Provider Communications
Joseph O’Riordan, Susan Panos, Ellen Gustavson, Ryan Francis, Stephen Wong,
Writers
Kristin Edmonston,
Production Coordinator
Kristina Cicelova,
Graphic Designer